Company Filing History:
Years Active: 2022
Title: Jackson Michuda: Innovator in Cancer Classification Technologies
Introduction
Jackson Michuda is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of cancer diagnostics. With a focus on innovative systems and methods, he has developed technologies that enhance the accuracy of cancer classification. His work is particularly relevant in the context of somatic tumor specimens, where precise diagnosis is crucial for effective treatment.
Latest Patents
Jackson Michuda holds a patent for "Systems and methods for multi-label cancer classification." This patent outlines a method that receives sequencing information derived from a somatic tumor specimen. The method identifies various features from the sequencing data, including RNA, DNA, RNA splicing, viral, and copy number features. By utilizing multiple classifiers, the method generates predictions regarding the cancer condition and combines these predictions to provide a definitive diagnosis for the subject's tumor specimen. This innovative approach represents a significant advancement in cancer diagnostics.
Career Highlights
Currently, Jackson Michuda is associated with Tempus Labs, Inc., a company that specializes in data-driven precision medicine. His role at Tempus Labs allows him to apply his expertise in cancer classification technologies, contributing to the development of solutions that improve patient outcomes. His work is characterized by a commitment to leveraging technology for better healthcare solutions.
Collaborations
Jackson collaborates with talented individuals in his field, including Kyle Ashley Beauchamp and Joshuah Kapilivsky. These collaborations enhance the innovative environment at Tempus Labs, fostering the development of cutting-edge technologies in cancer diagnostics.
Conclusion
Jackson Michuda's contributions to cancer classification technologies exemplify the impact of innovation in healthcare. His patent and work at Tempus Labs highlight the importance of advanced diagnostic methods in improving cancer treatment outcomes.